Japanese nationals in China decrease amid detention of expats, opaque judicial system
The number of Japanese nationals in China is decreasing amid the detention of expatriates working there and the country's ...
Healio2d
Latest data show progress of GA therapies in the pipeline
The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner’s New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema ...
Royalty Pharma Announces Upcoming Investor Day
Royalty Pharma plc (Nasdaq: RPRX) today announced that it will host an Investor Day in New York City on Thursday, September 11, 2025, starting at 8:30 a.m. ET. Royalty Pharma senior executives will ...
Bladder Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In March 2025, Merck Sharp & Dohme LLC announced a study are to learn if people who receive V940 and pembrolizumab are alive ...
The Bakersfield Californian6d
Singlera Genomics Presented Non-Invasive Testicular Toxicity Detection with Astellas at 2025 ...
Singlera Genomics presented results showing a refined approach to detect drug-induced testicular toxicity using Singlera’s cell-free DNA methylation technology with Astellas during ...
Salarius Pharmaceuticals, Inc.: Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating resp ...
The Japan Times7d
During visit to Beijing, CDP delegates affirm importance of Japan-China ties
Former CDP Secretary-General Katsuya Okada has called for stepping up interaction between 'high-level' Japanese and Chinese ...
Indies Pharma secures $60 million from first batch of FDA-approved drug
PHARMACEUTICAL company Indies Pharma Jamaica Limited has secured US$405,000 or just over $60 million in its first drawdown ...
Innate Pharma: Moving Into The Padcev Space
Innate Pharma continues its slow rollout of promising clinical candidates, with 2025 set for key milestones. Read more about ...
The Japan News9d
Detention of Japanese Astellas Pharma Employee in China May be Prolonged; Specific Actions that Led to Detention Not Revealed by Beijing
A Japanese man, who was detained by Chinese authorities, will likely continue to remain in detention despite the Japanese ...